Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6774632 | 0.85 | CDC25A (0.35) | — | |
| SCHEMBL1396771 | 0.84 | IDO1 (0.31) | IDO1TDO2 | |
| SCHEMBL5674761 | 0.82 | — | — | |
| SCHEMBL1396737 | 0.82 | CYP1A2 (0.31) | — | |
| SCHEMBL3198409 | 0.81 | — | — | |
| SCHEMBL2735995 | 0.81 | IDO1 (0.32) | IDO1TDO2 | |
| SCHEMBL13209034 | 0.81 | IDO1 (0.32) | IDO1TDO2 | |
| SCHEMBL31141331 | 0.81 | IDO1 (0.32) | IDO1TDO2 | |
| SCHEMBL1396689 | 0.81 | IDO1 (0.32) | IDO1TDO2 | |
| SCHEMBL3397401 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100034766-A1 | Malodor Counteracting Compositions | GIVAUDAN SA (CH) | 2010-02-11 | — | — | US | disclosed |
| EP-2079487-A1 | MALODOR COUNTERACTING COMPOSITIONS | Givaudan SA (CH) | 2009-07-22 | — | — | EP | disclosed |
| WO-2008049257-A1 | MALODOR COUNTERACTING COMPOSITIONS | GIVAUDAN SA (CH) | 2008-05-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100034766-A1 | Malodor Counteracting Compositions | MTNR1A, MTNR1B, MC4R | IDO1 2617/4885TDO2 1838/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.